BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/24/2020 10:13:26 AM | Browse: 1150 | Download: 2163
 |
Received |
|
2019-12-30 07:05 |
 |
Peer-Review Started |
|
2019-12-30 07:05 |
 |
First Decision by Editorial Office Director |
|
2020-02-19 23:19 |
 |
Return for Revision |
|
2020-02-26 01:35 |
 |
Revised |
|
2020-03-27 11:12 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2020-04-07 09:55 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2020-04-08 04:48 |
 |
Articles in Press |
|
2020-04-08 04:48 |
 |
Edit the Manuscript by Language Editor |
|
2020-04-11 10:04 |
 |
Typeset the Manuscript |
|
2020-04-21 02:43 |
 |
Publish the Manuscript Online |
|
2020-04-24 10:13 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Fang-Shu Cheng, Dan Pan, Bing Chang, Min Jiang and Li-Xuan Sang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Innovative Talent Support Program of the Institution of Higher Learning in Liaoning Province |
2018-478 |
| Innovative Talents of Science and Technology Support Program of Young and Middle People of Shenyang |
RC170446 |
|
| Corresponding Author |
Li-Xuan Sang, PhD, Assistant Professor, Chief Doctor, Department of Geriatrics, the First Affiliated Hospital, China Medical University, No. 155, Nanjing North Street, Heping District, Shenyang 110001, Liaoning Province, China. sanglixuan2008@163.com |
| Key Words |
VSL#3; Intestinal barrier function; Chronic diseases; Intestinal microbial balance; Cytokines; Therapeutic use |
| Core Tip |
The imbalance of intestinal microbiota is one of the important factors in multiple diseases. Probiotics have a benefit on human health as live microorganisms that can positively regulate the intestinal microbial composition. One probiotic mixture, VSL#3, consisting of eight live bacterial strains plays an essential function in preventing and treating digestive systemic and other systemic diseases in animals and humans. There is increasing evidence that VSL#3 works by modulating intestinal barrier function. It is able to improve tight junction protein function and the composition of intestinal microbiota and regulate immune-related cytokine expression. This review seeks to provide an overview of the role of VSL#3 in various kinds of diseases and its potential for clinical use in the future. |
| Publish Date |
2020-04-24 10:13 |
| Citation |
Cheng FS, Pan D, Chang B, Jiang M, Sang LX. Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases. World J Clin Cases 2020; 8(8): 1361-1384 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i8/1361.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i8.1361 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.